The 2018 Philippine Tuberculosis (TB) Drug Resistance Survey is the latest among a series of periodic nationwide surveillance activities spearheaded by the National Tuberculosis Reference Laboratory (NTRL). These surveys aim to measure the prevalence of drug-resistance in bacteriologically confirmed cases. The previous survey in 2021 found that the prevalence of multidrug-resistant tuberculosis (MDR-TB) was at continue reading : Strengthening Surveillance of Drug-Resistant Tuberculosis (TB)